Good performance status of long-term disease-free survivors of intracranial gliomas

Purpose : To determine the long-term impact on function of treatment for primary cerebral gliomas, Karnofsky Performance Status, employment history, and memory function were used to evaluate the status of adults who are alive and disease-free more than 1 year after cranial irradiation. Methods and M...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of radiation oncology, biology, physics biology, physics, 1993-04, Vol.26 (1), p.129-133
Hauptverfasser: Kleinberg, Lawrence, Wallner, Kent, Malkin, Mark G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 133
container_issue 1
container_start_page 129
container_title International journal of radiation oncology, biology, physics
container_volume 26
creator Kleinberg, Lawrence
Wallner, Kent
Malkin, Mark G
description Purpose : To determine the long-term impact on function of treatment for primary cerebral gliomas, Karnofsky Performance Status, employment history, and memory function were used to evaluate the status of adults who are alive and disease-free more than 1 year after cranial irradiation. Methods and Materials : Of 30 eligible adult patients, seventeen patients had anaplastic astrocytoma, seven had a glioblastoma, four had low grade astrocytoma, one had a mixed glioma, and one had an anaplastic oligodendroglioma. Sixteen patients received partial brain irradiation only, 12 had whole brain irradiation with a partial brain boost, and two had whole brain irradiation only. The total dose ranged from 54–66 Gy, with a fraction size of 1.7–2.0 Gy. Median follow-up was 3.5 years. Eighty-three percent of patients also received adjuvant chemotherapy. Results : Karnofsky Performance Status generally remained stable after the completion of irradiation. Mean Performance status was 84 at the end of irradiation and was unchanged at the time of last follow-up. The actuarial freedom from performance status decline after irradiation was 93% at 5 years. The performance status increased in two patients, both within several months of completing irradiation. Most patients (68%) returned to work after irradiation. Sixty-two percent remained at work 1 year later, and 58% were working at the time of last follow-up. No patient who did not return to work within 4 months of completing irradiation was able to work at a later date. All working patients were employed in a capacity similar to their pre-morbid position. Only one patient, with an intercurrent lung cancer, eventually developed deficits that limited self care. Conclusions : Contrary to previously published reports, long-term glioma survivors maintained a relatively good performance status in the absence of recurrence and did not experience a progressive decline in neuropsychologic function after completion of cranial irradiation. A patient's functional state at the completion of irradiation is a reliable predictor of long-term functional outcome in the absence of recurrence. Although the number of patients in each subgroup is small and no significant differences could be detected, patients treated with partial brain irradiation had a higher and more stable performance status, better memory function, and superior employment history.
doi_str_mv 10.1016/0360-3016(93)90183-V
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75730674</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>036030169390183V</els_id><sourcerecordid>75730674</sourcerecordid><originalsourceid>FETCH-LOGICAL-c503t-72a97b25732dab968b3fdfa85f7a789b5c0e928d6eb4386b72ea7a562d4f77243</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMoun78A4UeRPRQTZs2SS-CiK6C4MEPvIVpMpFI26xJu-C_t3WXPXqagXnel-Eh5DijlxnN-BVlnKZs3M4rdlHRTLL0fYvMMimqlJXlxzaZbZA9sh_jF6U0y0SxS3Ylk4LyYkZe5t6bZIHB-tBCpzGJPfRDTLxNGt99pj2GNjEuIkRMbcARGMLSLX34Y1zXB9ABOgdN8tk430I8JDsWmohH63lA3u7vXm8f0qfn-ePtzVOqS8r6VORQiTovBcsN1BWXNbPGgiytACGrutQUq1wajnXBJK9FjiCg5LkprBB5wQ7I2ap3Efz3gLFXrYsamwY69ENUYqymXExgsQJ18DEGtGoRXAvhR2VUTS7VJEpNolTF1J9L9T7GTtb9Q92i2YTW8sb76foOUUNjRwvaxQ1WCMYLOmHXKwxHF0uHQUXtcFRtXEDdK-Pd_3_8ApEkkOA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75730674</pqid></control><display><type>article</type><title>Good performance status of long-term disease-free survivors of intracranial gliomas</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Kleinberg, Lawrence ; Wallner, Kent ; Malkin, Mark G</creator><creatorcontrib>Kleinberg, Lawrence ; Wallner, Kent ; Malkin, Mark G</creatorcontrib><description>Purpose : To determine the long-term impact on function of treatment for primary cerebral gliomas, Karnofsky Performance Status, employment history, and memory function were used to evaluate the status of adults who are alive and disease-free more than 1 year after cranial irradiation. Methods and Materials : Of 30 eligible adult patients, seventeen patients had anaplastic astrocytoma, seven had a glioblastoma, four had low grade astrocytoma, one had a mixed glioma, and one had an anaplastic oligodendroglioma. Sixteen patients received partial brain irradiation only, 12 had whole brain irradiation with a partial brain boost, and two had whole brain irradiation only. The total dose ranged from 54–66 Gy, with a fraction size of 1.7–2.0 Gy. Median follow-up was 3.5 years. Eighty-three percent of patients also received adjuvant chemotherapy. Results : Karnofsky Performance Status generally remained stable after the completion of irradiation. Mean Performance status was 84 at the end of irradiation and was unchanged at the time of last follow-up. The actuarial freedom from performance status decline after irradiation was 93% at 5 years. The performance status increased in two patients, both within several months of completing irradiation. Most patients (68%) returned to work after irradiation. Sixty-two percent remained at work 1 year later, and 58% were working at the time of last follow-up. No patient who did not return to work within 4 months of completing irradiation was able to work at a later date. All working patients were employed in a capacity similar to their pre-morbid position. Only one patient, with an intercurrent lung cancer, eventually developed deficits that limited self care. Conclusions : Contrary to previously published reports, long-term glioma survivors maintained a relatively good performance status in the absence of recurrence and did not experience a progressive decline in neuropsychologic function after completion of cranial irradiation. A patient's functional state at the completion of irradiation is a reliable predictor of long-term functional outcome in the absence of recurrence. Although the number of patients in each subgroup is small and no significant differences could be detected, patients treated with partial brain irradiation had a higher and more stable performance status, better memory function, and superior employment history.</description><identifier>ISSN: 0360-3016</identifier><identifier>EISSN: 1879-355X</identifier><identifier>DOI: 10.1016/0360-3016(93)90183-V</identifier><identifier>PMID: 8387064</identifier><identifier>CODEN: IOBPD3</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Antineoplastic agents ; Astrocytoma - epidemiology ; Astrocytoma - radiotherapy ; Biological and medical sciences ; Brain Neoplasms - epidemiology ; Brain Neoplasms - radiotherapy ; Brain tumor ; Combined treatments (chemotherapy of immunotherapy associated with an other treatment) ; Employment ; Follow-Up Studies ; Glioblastoma - epidemiology ; Glioblastoma - radiotherapy ; Glioma ; Glioma - epidemiology ; Glioma - radiotherapy ; Humans ; Karnofsky performance status ; Medical sciences ; Memory ; Middle Aged ; Oligodendroglioma - epidemiology ; Oligodendroglioma - radiotherapy ; Pharmacology. Drug treatments ; Radiation ; Retrospective Studies ; Survival Analysis ; Time Factors</subject><ispartof>International journal of radiation oncology, biology, physics, 1993-04, Vol.26 (1), p.129-133</ispartof><rights>1993</rights><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c503t-72a97b25732dab968b3fdfa85f7a789b5c0e928d6eb4386b72ea7a562d4f77243</citedby><cites>FETCH-LOGICAL-c503t-72a97b25732dab968b3fdfa85f7a789b5c0e928d6eb4386b72ea7a562d4f77243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0360-3016(93)90183-V$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,780,784,789,790,3550,23930,23931,25140,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4736404$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8387064$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kleinberg, Lawrence</creatorcontrib><creatorcontrib>Wallner, Kent</creatorcontrib><creatorcontrib>Malkin, Mark G</creatorcontrib><title>Good performance status of long-term disease-free survivors of intracranial gliomas</title><title>International journal of radiation oncology, biology, physics</title><addtitle>Int J Radiat Oncol Biol Phys</addtitle><description>Purpose : To determine the long-term impact on function of treatment for primary cerebral gliomas, Karnofsky Performance Status, employment history, and memory function were used to evaluate the status of adults who are alive and disease-free more than 1 year after cranial irradiation. Methods and Materials : Of 30 eligible adult patients, seventeen patients had anaplastic astrocytoma, seven had a glioblastoma, four had low grade astrocytoma, one had a mixed glioma, and one had an anaplastic oligodendroglioma. Sixteen patients received partial brain irradiation only, 12 had whole brain irradiation with a partial brain boost, and two had whole brain irradiation only. The total dose ranged from 54–66 Gy, with a fraction size of 1.7–2.0 Gy. Median follow-up was 3.5 years. Eighty-three percent of patients also received adjuvant chemotherapy. Results : Karnofsky Performance Status generally remained stable after the completion of irradiation. Mean Performance status was 84 at the end of irradiation and was unchanged at the time of last follow-up. The actuarial freedom from performance status decline after irradiation was 93% at 5 years. The performance status increased in two patients, both within several months of completing irradiation. Most patients (68%) returned to work after irradiation. Sixty-two percent remained at work 1 year later, and 58% were working at the time of last follow-up. No patient who did not return to work within 4 months of completing irradiation was able to work at a later date. All working patients were employed in a capacity similar to their pre-morbid position. Only one patient, with an intercurrent lung cancer, eventually developed deficits that limited self care. Conclusions : Contrary to previously published reports, long-term glioma survivors maintained a relatively good performance status in the absence of recurrence and did not experience a progressive decline in neuropsychologic function after completion of cranial irradiation. A patient's functional state at the completion of irradiation is a reliable predictor of long-term functional outcome in the absence of recurrence. Although the number of patients in each subgroup is small and no significant differences could be detected, patients treated with partial brain irradiation had a higher and more stable performance status, better memory function, and superior employment history.</description><subject>Adult</subject><subject>Antineoplastic agents</subject><subject>Astrocytoma - epidemiology</subject><subject>Astrocytoma - radiotherapy</subject><subject>Biological and medical sciences</subject><subject>Brain Neoplasms - epidemiology</subject><subject>Brain Neoplasms - radiotherapy</subject><subject>Brain tumor</subject><subject>Combined treatments (chemotherapy of immunotherapy associated with an other treatment)</subject><subject>Employment</subject><subject>Follow-Up Studies</subject><subject>Glioblastoma - epidemiology</subject><subject>Glioblastoma - radiotherapy</subject><subject>Glioma</subject><subject>Glioma - epidemiology</subject><subject>Glioma - radiotherapy</subject><subject>Humans</subject><subject>Karnofsky performance status</subject><subject>Medical sciences</subject><subject>Memory</subject><subject>Middle Aged</subject><subject>Oligodendroglioma - epidemiology</subject><subject>Oligodendroglioma - radiotherapy</subject><subject>Pharmacology. Drug treatments</subject><subject>Radiation</subject><subject>Retrospective Studies</subject><subject>Survival Analysis</subject><subject>Time Factors</subject><issn>0360-3016</issn><issn>1879-355X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LxDAQhoMoun78A4UeRPRQTZs2SS-CiK6C4MEPvIVpMpFI26xJu-C_t3WXPXqagXnel-Eh5DijlxnN-BVlnKZs3M4rdlHRTLL0fYvMMimqlJXlxzaZbZA9sh_jF6U0y0SxS3Ylk4LyYkZe5t6bZIHB-tBCpzGJPfRDTLxNGt99pj2GNjEuIkRMbcARGMLSLX34Y1zXB9ABOgdN8tk430I8JDsWmohH63lA3u7vXm8f0qfn-ePtzVOqS8r6VORQiTovBcsN1BWXNbPGgiytACGrutQUq1wajnXBJK9FjiCg5LkprBB5wQ7I2ap3Efz3gLFXrYsamwY69ENUYqymXExgsQJ18DEGtGoRXAvhR2VUTS7VJEpNolTF1J9L9T7GTtb9Q92i2YTW8sb76foOUUNjRwvaxQ1WCMYLOmHXKwxHF0uHQUXtcFRtXEDdK-Pd_3_8ApEkkOA</recordid><startdate>19930430</startdate><enddate>19930430</enddate><creator>Kleinberg, Lawrence</creator><creator>Wallner, Kent</creator><creator>Malkin, Mark G</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19930430</creationdate><title>Good performance status of long-term disease-free survivors of intracranial gliomas</title><author>Kleinberg, Lawrence ; Wallner, Kent ; Malkin, Mark G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c503t-72a97b25732dab968b3fdfa85f7a789b5c0e928d6eb4386b72ea7a562d4f77243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Adult</topic><topic>Antineoplastic agents</topic><topic>Astrocytoma - epidemiology</topic><topic>Astrocytoma - radiotherapy</topic><topic>Biological and medical sciences</topic><topic>Brain Neoplasms - epidemiology</topic><topic>Brain Neoplasms - radiotherapy</topic><topic>Brain tumor</topic><topic>Combined treatments (chemotherapy of immunotherapy associated with an other treatment)</topic><topic>Employment</topic><topic>Follow-Up Studies</topic><topic>Glioblastoma - epidemiology</topic><topic>Glioblastoma - radiotherapy</topic><topic>Glioma</topic><topic>Glioma - epidemiology</topic><topic>Glioma - radiotherapy</topic><topic>Humans</topic><topic>Karnofsky performance status</topic><topic>Medical sciences</topic><topic>Memory</topic><topic>Middle Aged</topic><topic>Oligodendroglioma - epidemiology</topic><topic>Oligodendroglioma - radiotherapy</topic><topic>Pharmacology. Drug treatments</topic><topic>Radiation</topic><topic>Retrospective Studies</topic><topic>Survival Analysis</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kleinberg, Lawrence</creatorcontrib><creatorcontrib>Wallner, Kent</creatorcontrib><creatorcontrib>Malkin, Mark G</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of radiation oncology, biology, physics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kleinberg, Lawrence</au><au>Wallner, Kent</au><au>Malkin, Mark G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Good performance status of long-term disease-free survivors of intracranial gliomas</atitle><jtitle>International journal of radiation oncology, biology, physics</jtitle><addtitle>Int J Radiat Oncol Biol Phys</addtitle><date>1993-04-30</date><risdate>1993</risdate><volume>26</volume><issue>1</issue><spage>129</spage><epage>133</epage><pages>129-133</pages><issn>0360-3016</issn><eissn>1879-355X</eissn><coden>IOBPD3</coden><abstract>Purpose : To determine the long-term impact on function of treatment for primary cerebral gliomas, Karnofsky Performance Status, employment history, and memory function were used to evaluate the status of adults who are alive and disease-free more than 1 year after cranial irradiation. Methods and Materials : Of 30 eligible adult patients, seventeen patients had anaplastic astrocytoma, seven had a glioblastoma, four had low grade astrocytoma, one had a mixed glioma, and one had an anaplastic oligodendroglioma. Sixteen patients received partial brain irradiation only, 12 had whole brain irradiation with a partial brain boost, and two had whole brain irradiation only. The total dose ranged from 54–66 Gy, with a fraction size of 1.7–2.0 Gy. Median follow-up was 3.5 years. Eighty-three percent of patients also received adjuvant chemotherapy. Results : Karnofsky Performance Status generally remained stable after the completion of irradiation. Mean Performance status was 84 at the end of irradiation and was unchanged at the time of last follow-up. The actuarial freedom from performance status decline after irradiation was 93% at 5 years. The performance status increased in two patients, both within several months of completing irradiation. Most patients (68%) returned to work after irradiation. Sixty-two percent remained at work 1 year later, and 58% were working at the time of last follow-up. No patient who did not return to work within 4 months of completing irradiation was able to work at a later date. All working patients were employed in a capacity similar to their pre-morbid position. Only one patient, with an intercurrent lung cancer, eventually developed deficits that limited self care. Conclusions : Contrary to previously published reports, long-term glioma survivors maintained a relatively good performance status in the absence of recurrence and did not experience a progressive decline in neuropsychologic function after completion of cranial irradiation. A patient's functional state at the completion of irradiation is a reliable predictor of long-term functional outcome in the absence of recurrence. Although the number of patients in each subgroup is small and no significant differences could be detected, patients treated with partial brain irradiation had a higher and more stable performance status, better memory function, and superior employment history.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>8387064</pmid><doi>10.1016/0360-3016(93)90183-V</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0360-3016
ispartof International journal of radiation oncology, biology, physics, 1993-04, Vol.26 (1), p.129-133
issn 0360-3016
1879-355X
language eng
recordid cdi_proquest_miscellaneous_75730674
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adult
Antineoplastic agents
Astrocytoma - epidemiology
Astrocytoma - radiotherapy
Biological and medical sciences
Brain Neoplasms - epidemiology
Brain Neoplasms - radiotherapy
Brain tumor
Combined treatments (chemotherapy of immunotherapy associated with an other treatment)
Employment
Follow-Up Studies
Glioblastoma - epidemiology
Glioblastoma - radiotherapy
Glioma
Glioma - epidemiology
Glioma - radiotherapy
Humans
Karnofsky performance status
Medical sciences
Memory
Middle Aged
Oligodendroglioma - epidemiology
Oligodendroglioma - radiotherapy
Pharmacology. Drug treatments
Radiation
Retrospective Studies
Survival Analysis
Time Factors
title Good performance status of long-term disease-free survivors of intracranial gliomas
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T08%3A44%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Good%20performance%20status%20of%20long-term%20disease-free%20survivors%20of%20intracranial%20gliomas&rft.jtitle=International%20journal%20of%20radiation%20oncology,%20biology,%20physics&rft.au=Kleinberg,%20Lawrence&rft.date=1993-04-30&rft.volume=26&rft.issue=1&rft.spage=129&rft.epage=133&rft.pages=129-133&rft.issn=0360-3016&rft.eissn=1879-355X&rft.coden=IOBPD3&rft_id=info:doi/10.1016/0360-3016(93)90183-V&rft_dat=%3Cproquest_cross%3E75730674%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75730674&rft_id=info:pmid/8387064&rft_els_id=036030169390183V&rfr_iscdi=true